The expression of CD80, CD86 and HLA-DR molecules was evaluated in CD14−CD123+ plasmacytoid dendritic cells (pDCs) from cancer patients, before and after chemotherapy, upon ex vivo treatment with the adjuvants. This evidence concerns the gene CD80 and cancer.